These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 1990703)

  • 1. Cluster-function relationship of anti-P55 IL-2 receptor monoclonal antibodies in mice.
    Dantal J; Jacques Y; Soulillou JP
    Transplant Proc; 1991 Feb; 23(1 Pt 1):826-7. PubMed ID: 1990703
    [No Abstract]   [Full Text] [Related]  

  • 2. A newly established anti-interleukin-2 receptor beta chain (P75) monoclonal antibody inhibits the induction of allo-specific cytotoxic lymphocytes in combination with anti-interleukin-2 receptor alpha chain (P55) monoclonal antibody.
    Niguma T; Sakagami K; Orita K
    Transplant Proc; 1991 Feb; 23(1 Pt 1):290-4. PubMed ID: 1990535
    [No Abstract]   [Full Text] [Related]  

  • 3. Cluster-function relationship of rat-antimouse P55 IL-2 receptor monoclonal antibodies. In vitro studies of the CTL-L2 mouse cell line and in vivo studies in a delayed-type hypersensitivity model in mice.
    Dantal J; Jacques Y; Soulillou JP
    Transplantation; 1991 Jul; 52(1):110-5. PubMed ID: 1858138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppression by anti-interleukin-2 receptor antibody but not anti-L3T4 requires terminal complement components.
    Kelley VE; Strom TB
    Transplant Proc; 1987 Feb; 19(1 Pt 1):617. PubMed ID: 3274827
    [No Abstract]   [Full Text] [Related]  

  • 5. The murine IL 2 receptor. II. Monoclonal anti-IL 2 receptor antibodies as specific inhibitors of T cell function in vitro.
    Malek TR; Ortega G; Jakway JP; Chan C; Shevach EM
    J Immunol; 1984 Oct; 133(4):1976-82. PubMed ID: 6432904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphokine-induced cytotoxicity: requirement of two lymphokines for the induction of optimal cytotoxic response.
    Yang SS; Malek TR; Hargrove ME; Ting CC
    J Immunol; 1985 Jun; 134(6):3912-9. PubMed ID: 3921614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recruitment and activation of tumor-specific immune T cells in situ. CD8+ cells predominate the secondary response in sponge matrices and exert both delayed-type hypersensitivity-like and cytotoxic T lymphocyte activity.
    Zangemeister-Wittke U; Kyewski B; Schirrmacher V
    J Immunol; 1989 Jul; 143(1):379-85. PubMed ID: 2499633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of presensitization with IL-2 receptor antibody plus alloantigen.
    Tyler JD; Wierwille SL; Goldman MH
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1010-2. PubMed ID: 2650062
    [No Abstract]   [Full Text] [Related]  

  • 9. Description of phenotypically distinct T-lymphocyte subsets which mediate helper/DTH and cytotoxic functions in the Syrian hamster.
    Witte PL; Stein-Streilein J; Streilein JW
    J Immunol; 1985 May; 134(5):2908-15. PubMed ID: 2858506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of IL 2 receptor expression and cytotoxicity of thymocytes by stimulation with TCF1.
    Falk W; Männel DN; Katzer B; Kaltmann B; Krammer PH; Diamantstein T; Dröge W
    J Immunol; 1985 Aug; 135(2):1160-4. PubMed ID: 3924999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-12 can replace CD28-dependent T-cell costimulation during nonspecific cytotoxic T lymphocyte induction by anti-CD3 antibody.
    Makrigiannis AP; Musgrave BL; Haeryfar SM; Hoskin DW
    J Leukoc Biol; 2001 Jan; 69(1):113-22. PubMed ID: 11200055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effects of anti-interleukin 2 receptor and anti-L3T4 antibodies on delayed type hypersensitivity: the role of complement and epitope.
    Kelley VE; Gaulton GN; Strom TB
    J Immunol; 1987 May; 138(9):2771-5. PubMed ID: 3106488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal cytotoxic T lymphocyte hybridomas capable of specific killing activity, antigenic responsiveness, and inducible interleukin secretion.
    Kaufmann Y; Berke G
    J Immunol; 1983 Jul; 131(1):50-6. PubMed ID: 6190926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concerted action of monoclonal antibodies directed at the P55 and P75 chains of the human interleukin-2 receptor.
    Jacques Y; Audrain M; Boeffard F; Soulillou JP
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1068-9. PubMed ID: 1989151
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of treatment with IL-2 receptor specific monoclonal antibody in mice. Inhibition of cytotoxic T cell responses but not of T help.
    Leist TP; Kohler M; Eppler M; Zinkernagel RM
    J Immunol; 1989 Jul; 143(2):628-32. PubMed ID: 2544648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A rat anti-mouse T4 monoclonal antibody (H129.19) inhibits the proliferation of Ia-reactive T cell clones and delineates two phenotypically distinct (T4+, Lyt-2,3-, and T4-, Lyt-2,3+) subsets among anti-Ia cytolytic T cell clones.
    Pierres A; Naquet P; Van Agthoven A; Bekkhoucha F; Denizot F; Mishal Z; Schmitt-Verhulst AM; Pierres M
    J Immunol; 1984 Jun; 132(6):2775-82. PubMed ID: 6202760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of anti-Lyt-2 and anti-L3T4 monoclonal antibodies on the function of cytotoxic T lymphocyte/helper T lymphocyte hybrid T cell clones.
    Havran WL; Fitch FW
    J Immunol; 1988 Sep; 141(6):1808-12. PubMed ID: 2459190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of accessory molecules in signal transduction of cytolytic T lymphocyte by anti-T cell receptor and anti-Ly-6.2C monoclonal antibodies.
    Leo O; Foo M; Henkart PA; Perez P; Shinohara N; Segal DM; Bluestone JA
    J Immunol; 1987 Dec; 139(11):3556-63. PubMed ID: 3316387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterologous cross-linking of Lyt-2 (CD8) to the alpha beta-T cell receptor is more effective in T cell activation than homologous alpha beta-T cell receptor cross-linking.
    Boyce NW; Jönsson JI; Emmrich F; Eichmann K
    J Immunol; 1988 Nov; 141(9):2882-8. PubMed ID: 3262671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-CD3:anti-IL-2 receptor bispecific monoclonal antibody. Targeting of activated T cells in vitro.
    MacLean JA; Su Z; Guo Y; Sy MS; Colvin RB; Wong JT
    J Immunol; 1993 Feb; 150(4):1619-28. PubMed ID: 8432997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.